Sleep becomes precious during the final week of the Tour de France. Every hour matters when riders must recover from mountain stages, replace thousands of calories and prepare their bodies to climb again.
Antidoping officers knocked on Jonas Vingegaard’s hotel door at 2 a.m. before stage 15. They arrived at Tadej Pogacar’s room at 5 a.m. The Guardian reported that both controls took place outside the usual testing window and required approval from a Paris judge.
Later that day, Vingegaard clipped a kerb while the peloton exited a turn, crashed and fractured his collarbone. He abandoned the race because of the injury. No evidence directly links the interrupted sleep to the accident, although Pogacar questioned whether the disruption might have affected his rival’s concentration.
Paul Seixas received his control on Monday evening instead. That difference pushed Matej Mohoric, another rider visited at 5 a.m., to ask whether every contender faced the same burden.
The Cost of a Knock Before Dawn
A rider does not begin resting the moment a Tour stage ends. First comes the return to the team bus. Then follows the hotel transfer, food, massage, medical treatment, team meetings, and another meal.
Mountain stages make that routine even harder. Riders spend hours fighting steep gradients before trying to replace the energy burned on the road. Some do not reach bed until close to midnight.
Mohoric said a 5 a.m. control cut through the middle of his sleeping period. Breakfast and the transfer to the next start followed only a few hours later. The test itself may take little time, but falling asleep again presents another problem.
Vingegaard faced an even more severe interruption. Officers reached him at 2 a.m. before a demanding Alpine stage that finished at Plateau de Solaison. The Dane accepted the need for testing but questioned a process that could damage recovery before 1 of the hardest days of the race.
Pogacar called the timing inhuman. Remco Evenepoel also argued that testing officials needed to show greater respect for a rider’s sleep.
Those complaints did not challenge the existence of antidoping controls. The peloton understands why cycling receives intense scrutiny. Modern doping methods can involve small doses and narrow detection windows, while the sport still carries the damage caused by previous scandals.
The timing created the anger. Some major contenders had been dragged from bed in darkness. Others received visits while they were still awake.
Speaking to Slovenian outlet Sportal before stage 17, Mohoric placed Seixas directly inside that argument.
“It would be good to guarantee equal treatment for everyone,” Matej Mohoric said.
Mohoric pointed out that Seixas, then sitting 4th in the general classification, had not undergone a comparable nighttime control. He offered no evidence that French officials had protected the teenager. His criticism focused on the clear difference in how testing disrupted each rider’s recovery.
Why Seixas Became the Flashpoint
Seixas was always likely to attract attention. He entered his 1st Tour at 19 and quickly emerged as France’s leading hope in the general classification. By the final week, he remained close to the podium and carried the expectations of a country still waiting for another home winner.
France has not celebrated a Tour champion of its own since Bernard Hinault in 1985. Every strong Seixas performance has brought excitement, pressure and scrutiny.
Officers tested Seixas and the rest of his Decathlon squad on Monday evening. The control formed part of a wider biological passport operation involving every rider still in the Tour.
That detail matters. Seixas did not avoid testing. He simply had not received the type of overnight visit imposed on Pogacar, Vingegaard, and Mohoric. The difference concerned timing, not whether officials had collected a sample.
Nobody has accused Seixas of returning a positive result. A daytime test does not prove protection, just as a 2 a.m. visit does not establish guilt.
Seixas is caught in the dispute because he is young, French, and threatening the podium. The responsibility for explaining the testing schedule belongs to the authorities, not to the rider who opened his door when officers arrived.
What Targeted Testing Really Means
The International Testing Agency rejected claims of French influence. It said French antidoping personnel may help collect samples, but the ITA decides which riders to test and when each control takes place.
Officials said they rely on performance information, biological results, scientific findings, private intelligence and individual risk assessments. In plain English, an unexpected change in a rider’s biological passport or credible information about possible microdosing could make that rider a priority.
The agency cannot reveal every reason behind a specific visit. Doing so could expose its methods and help anyone attempting to avoid detection. That secrecy supports the testing program, but it also makes visible differences harder for riders to accept.
French law places another barrier around nighttime controls. A judge must approve testing between 11 p.m. and 6 a.m., and officials need specific grounds before requesting that authority. The controls involving Pogacar and Vingegaard received that judicial approval.
Tour director Christian Prudhomme later defended the independence of the process. He said race organizers receive no advance warning about testing targets and play no part in deciding which riders receive visits.
The UCI also supported the program while acknowledging the physical cost. Cycling’s governing body described nighttime controls as exceptional measures for limited and justified circumstances because they can damage sleep and recovery.
Equal Rules Can Still Produce Unequal Nights
Targeted testing cannot mean identical testing. An effective antidoping system must follow evidence rather than visit every contender at the same hour simply to make the schedule look balanced.
Appearances still matter in a sport where trust remains fragile. Riders see 1 contender awakened at 2 a.m., another disturbed at 5 a.m., and a French podium threat tested during the evening. Without a fuller explanation, those differences invite suspicion.
The authorities do not need to publish private intelligence or reveal every method used to detect microdosing. They should explain why the most disruptive controls become necessary and what safeguards stop nationality, popularity, or race position from influencing the decision.
Mohoric raised a legitimate question. The ITA offered a credible defense. Neither side completely resolved the tension.
When the Tour reaches gradients above 10 percent, poor sleep follows riders onto the road. Legs respond more slowly. Concentration fades. A mistake on a descent or at a crowded roundabout can erase 3 weeks of work.
Cycling needs aggressive testing to protect the race. It also needs riders to believe that every knock on a hotel door follows evidence rather than the flag outside the room.
READ MORE – Jasper Philipsen Ends Tour de France Drought With Stage 17 Victory in Voiron
FAQs
Why were Pogacar and Vingegaard tested during the night?
The controls were targeted and received judicial approval. Officials have not publicly revealed the specific intelligence behind either visit.
Was Paul Seixas accused of doping?
No. Seixas underwent testing with his team, and nobody has accused him of returning a positive result or avoiding a control.
Who decides which Tour de France riders are tested?
The International Testing Agency selects the riders and schedules the controls. Tour organisers and French sample collectors do not choose the targets.
Why are riders angry about nighttime antidoping tests?
Tests at 2 a.m. or 5 a.m. interrupt sleep and recovery. Riders fear that fatigue could affect concentration and performance during difficult stages.
Are nighttime antidoping tests allowed in France?
Yes, but officials need specific grounds and judicial approval for controls conducted between 11 p.m. and 6 a.m.
